New heart valve fix without open surgery: early trial begins
Disease control
Recruiting now
This early study is testing a new device called MitraFix® for people with a severe leaky heart valve (mitral regurgitation) who are too high-risk for open-heart surgery. The device is implanted through a small tube in a leg vein. The main goals are to see if the procedure is safe…
Phase: NA • Sponsor: Mitrassist Lifesciences Limited Co., Ltd. • Aim: Disease control
Last updated Jun 27, 2026 12:03 UTC